SG

Swati Goswami

Director Additional Director DIN 01896827
DIN 01896827 First appointment Dec 2006 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Swati Goswami

Data last updated:

Swati Goswami was an Additional Director at Omen Drugs Pvt Ltd (2006–2007) and Designated Partner at Omen Drugs Llp (from 2014). The companies operate in Chemicals.

DIN 01896827
Primary Designation Additional Director
Industry Chemicals
First Appointment 26 Dec 2006
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Omen Drugs Pvt Ltd U24232MP1985PTC002928
Additional Director26 Dec 20061985Converted To Llp
Omen Drugs Llp AAA-9296
Designated Partner21 Jul 20142012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Omen Drugs Llp
Omen Drugs Pvt Ltd
Premium access

Shareholding and investment profile for Swati Goswami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Goswami

Swati Goswami was first appointed on 26 Dec 2006 as Additional Director at Omen Drugs Pvt Ltd. The most recent appointment on record is 21 Jul 2014 at Omen Drugs Llp.

Swati Goswami held 2 earlier board appointments: Omen Drugs Pvt Ltd (Additional Director, 26 Dec 2006 to 01 Oct 2007); Omen Drugs Llp (Designated Partner, from 21 Jul 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available